This company has been acquired
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Cardiovascular Systems Crescita futura
Future criteri di controllo 1/6
Informazioni chiave
35.4%
Tasso di crescita degli utili
34.2%
Tasso di crescita dell'EPS
| Medical Equipment crescita degli utili | 17.5% |
| Tasso di crescita dei ricavi | 11.1% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Good |
| Ultimo aggiornamento | 09 Feb 2023 |
Aggiornamenti recenti sulla crescita futura
Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03
We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11
Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 6/30/2025 | 321 | -12 | N/A | N/A | 2 |
| 6/30/2024 | 283 | -19 | N/A | N/A | 6 |
| 6/30/2023 | 257 | -27 | N/A | N/A | 6 |
| 12/31/2022 | 240 | -38 | -34 | -29 | N/A |
| 9/30/2022 | 238 | -39 | -31 | -27 | N/A |
| 6/30/2022 | 236 | -37 | -28 | -24 | N/A |
| 3/31/2022 | 245 | -33 | -17 | -13 | N/A |
| 12/31/2021 | 252 | -29 | -17 | -13 | N/A |
| 9/30/2021 | 257 | -20 | -13 | -10 | N/A |
| 6/30/2021 | 259 | -13 | -5 | -1 | N/A |
| 3/31/2021 | 231 | -23 | -18 | -14 | N/A |
| 12/31/2020 | 228 | -20 | -16 | -11 | N/A |
| 9/30/2020 | 233 | -24 | -14 | -9 | N/A |
| 6/30/2020 | 237 | -27 | -17 | -13 | N/A |
| 3/31/2020 | 262 | -11 | 0 | 4 | N/A |
| 12/31/2019 | 264 | -7 | 1 | 5 | N/A |
| 9/30/2019 | 256 | -3 | 2 | 6 | N/A |
| 6/30/2019 | 248 | 0 | 7 | 10 | N/A |
| 3/31/2019 | 239 | 2 | 9 | 13 | N/A |
| 12/31/2018 | 231 | 2 | 11 | 14 | N/A |
| 9/30/2018 | 224 | 1 | 8 | 11 | N/A |
| 6/30/2018 | 217 | 2 | 7 | 10 | N/A |
| 3/31/2018 | 211 | -1 | 2 | 5 | N/A |
| 12/31/2017 | 207 | -3 | 2 | 5 | N/A |
| 9/30/2017 | 205 | -2 | 17 | 19 | N/A |
| 6/30/2017 | 205 | -2 | 18 | 20 | N/A |
| 3/31/2017 | 199 | -7 | 11 | 13 | N/A |
| 12/31/2016 | 191 | -28 | 6 | 8 | N/A |
| 9/30/2016 | 183 | -45 | N/A | -21 | N/A |
| 6/30/2016 | 177 | -56 | N/A | -24 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: CSII is forecast to remain unprofitable over the next 3 years.
Guadagni vs Mercato: CSII is forecast to remain unprofitable over the next 3 years.
Guadagni ad alta crescita: CSII is forecast to remain unprofitable over the next 3 years.
Ricavi vs Mercato: CSII's revenue (11.1% per year) is forecast to grow faster than the US market (7% per year).
Ricavi ad alta crescita: CSII's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if CSII's Return on Equity is forecast to be high in 3 years time